Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,456
  • Shares Outstanding, K 11,532
  • Annual Sales, $ 1,300 K
  • Annual Income, $ -10,280 K
  • EBIT $ -5 M
  • EBITDA $ -4 M
  • 60-Month Beta 1.17
  • Price/Sales 5.86
  • Price/Cash Flow N/A
  • Price/Book 0.32
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings $-0.05 on 11/12/24
  • Next Earnings Date 04/04/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 557.97% ( +320.81%)
  • Historical Volatility 124.49%
  • IV Percentile 97%
  • IV Rank 75.11%
  • IV High 734.74% on 01/06/25
  • IV Low 24.45% on 07/09/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 397
  • Open Int (30-Day) 260

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7200 +20.14%
on 03/14/25
1.6600 -47.89%
on 02/21/25
-0.1450 (-14.36%)
since 02/20/25
3-Month
0.7000 +23.57%
on 12/31/24
2.4400 -64.55%
on 01/03/25
-0.2450 (-22.07%)
since 12/20/24
52-Week
0.7000 +23.57%
on 12/31/24
2.4400 -64.55%
on 01/03/25
-1.4850 (-63.19%)
since 03/20/24

Most Recent Stories

More News
TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD: Q3 Earnings Snapshot

TXMD : 0.8650 (+5.49%)
TherapeuticsMD: Q2 Earnings Snapshot

TherapeuticsMD: Q2 Earnings Snapshot

TXMD : 0.8650 (+5.49%)
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 0.8650 (+5.49%)
TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD: Q3 Earnings Snapshot

TXMD : 0.8650 (+5.49%)
TherapeuticsMD: Q2 Earnings Snapshot

TherapeuticsMD: Q2 Earnings Snapshot

TXMD : 0.8650 (+5.49%)
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 0.8650 (+5.49%)
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December...

TXMD : 0.8650 (+5.49%)
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has completed its previously announced...

TXMD : 0.8650 (+5.49%)
Pre-Market Brief: Stocks Mixed As Labor Market Strength Weigh On Sentiment

December S&P 500 futures (ESZ22) are trending down -0.30% this morning after three major US benchmark indices closed mixed on Friday as the November payrolls report fueled expectations the Federal Reserve...

ESZ22 : 3,871.47s (-0.66%)
TXMD : 0.8650 (+5.49%)
IOVA : 3.57 (+0.28%)
IMPP : 2.54 (-0.39%)
CLVS : 0.0812 (-5.58%)
UTHR : 313.43 (-1.70%)
SBUX : 99.20 (+0.01%)
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements...

TXMD : 0.8650 (+5.49%)

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

3rd Resistance Point 0.9707
2nd Resistance Point 0.9103
1st Resistance Point 0.8652
Last Price 0.8650
1st Support Level 0.7597
2nd Support Level 0.6993
3rd Support Level 0.6542

See More

52-Week High 2.4400
Fibonacci 61.8% 1.7753
Fibonacci 50% 1.5700
Fibonacci 38.2% 1.3647
Last Price 0.8650
52-Week Low 0.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar